What is the Innovative SME recognition for NeuronUP?

The Innovative SME recognition from the Ministry of Science, Innovation and Universities designates NeuronUP as an R&D‑driven company; only three out of every 1,000 Spanish SMEs hold this seal.

Why is the Innovative SME recognition significant for neurorehabilitation?

The seal endorses NeuronUP's commitment to R&D&I in neurorehabilitation, supporting development of evidence‑based digital therapies and technology that aim to improve patient outcomes.

How did NeuronUP obtain the Innovative SME seal?

The certification requires companies to demonstrate recent R&D&I activities and evidence of innovation; NeuronUP qualified through sustained research, data analysis and technological development.

Who leads NeuronUP's R&D&I department?

The R&D&I department is led by Jesús Cortes, PhD in Computational Physics, who brings more than 20 years of experience in neuroscience research and hospital data applications.

How will the Innovative SME certification affect healthcare professionals and patients?

The certification aims to enhance tools for healthcare professionals and maximize patient benefit by promoting innovative, data‑driven neurorehabilitation solutions and continuous clinical research.

What is NeuronUP's global reach and user base?

NeuronUP serves over 50,000 users across more than 50 countries, demonstrating international adoption of its neurorehabilitation platform and digital therapeutic resources.

NeuronUP achieves the ‘Innovative SME’ seal

NeuronUP has been recognized as an Innovative SME by the Ministry of Science, Innovation and Universities, an accolade held by only three out of every 1,000 small and medium-sized enterprises in Spain. This recognition endorses the company’s commitment to research, development and innovation (R&D&I) in the field of neurorehabilitation.

A DNA defined by innovation

NeuronUP’s CEO, Íñigo Fernández de Piérola, emphasizes that “innovation has been in NeuronUP’s DNA since its inception, and obtaining this seal reinforces our innovative culture, which has allowed us to reach more than 50,000 users in over 50 countries.”

Along these lines, he underlines the importance of technology and research as fundamental pillars of the company. “We have always been clear that our main goal is to improve the day-to-day life of healthcare professionals and maximize the benefit to patients through innovation, research and the analysis of the millions of data points we generate.”

An R&D&I team at the service of neurorehabilitation

“We have always been clear that our main objective is to improve the day-to-day life of healthcare professionals and achieve the maximum benefit for patients through innovation, research and the millions of data points we generate,” emphasizes the CEO.

NeuronUP has its own R&D&I department, led by Jesús Cortes, PhD in Computational Physics, with more than 20 years of experience in research and data in Neuroscience and hospital settings. His work reinforces the company’s commitment to developing innovative solutions based on data and the latest scientific evidence.

How is the Innovative SME seal obtained?

To obtain this distinction, companies must demonstrate that they have carried out R&D&I activities in recent years, evidencing their innovative character. With this certification, NeuronUP consolidates its position as a technological and innovative company, reaffirming its commitment to advancing neurorehabilitation and supporting healthcare professionals.